| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/24/2009 | US7495127 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity; pimaric acid, dihydropimaric acid, dihydroisopimarinol, sandaracopimaric acid, isopimaric acid, and dihydroisopimaric acid |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2297406C Tricyclic vasopressin agonists |
| 02/19/2009 | WO2008157205A3 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 02/19/2009 | WO2008018827A8 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/19/2009 | WO2006065484A3 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048304 Crystal Form of Besipirdine Chlorhydrate, Process Preparation and Use Thereof |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | CN101371142A Method of diagnosis and method of treatment |
| 02/18/2009 | CN101367862A Method for quickly and massively separating high purity triptolide from thunder god vine |
| 02/18/2009 | CN101366941A Traditional Chinese medicine capsule for treating cold symptoms type nephritis |
| 02/18/2009 | CN101366896A Traditional Chinese medicine for treating chronic prostatitis and preparation method thereof |
| 02/18/2009 | CN101366716A Application of Raloxifene compounds in preparing medicament for preventing and controlling benign prostatahyperplasie |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462094C Chinese-medicinal preparation for treating urinary system disease |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2348380C Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 02/17/2009 | CA2282812C Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 02/12/2009 | WO2008128028A3 Solifenacin compositions |
| 02/12/2009 | US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
| 02/12/2009 | US20090042970 Methods and devices for desmopressin drug delivery |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042841 Novel heterocyclic derivatives as m-glu5 antagonists |
| 02/12/2009 | US20090042826 Use of the AXL receptor for diagnosis and treatment of renal disease |
| 02/12/2009 | US20090041877 Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 02/12/2009 | US20090041727 Compositions and Methods for Microbe Storage and Delivery |
| 02/12/2009 | US20090041726 Tumor therapy with high affinity laminin receptor-target vectors and combinations with chemotherapeutic agents |
| 02/12/2009 | US20090041719 Method for screening therapeutic agent for glomerular disorder |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2022492A1 Anti-cancer pharmaceutical composition |
| 02/11/2009 | EP2021012A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake |
| 02/11/2009 | EP2020997A2 Novel actives against prostate carcinoma |
| 02/11/2009 | EP2020873A2 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | CN101365684A Indazole derivatives that inhibit trpv1 receptor |
| 02/11/2009 | CN101361954A Traditional Chinese medicine formulation for treating elderly nephritis |
| 02/11/2009 | CN101361943A Production method of capsule for conditioning and treating kidney deficiency |
| 02/11/2009 | CN101361885A Chinese traditional medicine composition for treating the prostatitis and preparation method thereof |
| 02/11/2009 | CN101361856A Traditional Chinese medicine oral liquid for treating lithiasis |
| 02/11/2009 | CN101361807A Medicine for treating sphincter disturbance |
| 02/11/2009 | CN101361786A Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides |
| 02/11/2009 | CN101361763A Pollen hormone freeze dehydration method |
| 02/11/2009 | CN101361762A Spray-draying method of pollen hormone |
| 02/11/2009 | CN101361739A Anti-bacteria agent for parenteral administration |
| 02/11/2009 | CN101361732A Medicinal preparation containing garcinia acid and use thereof |
| 02/11/2009 | CN100460002C Chinese medicine composition for treating various kinds of inflammation and cyst |
| 02/10/2009 | US7488735 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 02/10/2009 | US7488734 Anticancer agents; hormone replacement therapy; contraceptives |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/10/2009 | CA2352561C Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/05/2009 | WO2009017161A1 Inhibitory agent for inflammatory cytokine |
| 02/05/2009 | WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/05/2009 | US20090036526 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036508 Amino indazole derivatives |
| 02/05/2009 | US20090036496 Treatment of Stress Urinary Incontinence and Mixed Urinary Incontinence |
| 02/05/2009 | US20090036455 Arylpiperazine derivative and use thereof as 5-ht1a receptor ligands |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036400 Pharmaceutical Preparations for Treating the Consequences of Alcohol Abuse, Hepatitis, Pancreatitis, Alzheimer's Disease, Parkinson's Disease, Diabetes, Toxic Kidney Disease, Reperfusion Damage, Arteriosclerosis, and as an Antidote Against Environmental Toxins and Medicinal Intoxication |
| 02/05/2009 | US20090035372 method for manufacturing a pharmaceutical composition for controlled release of an active substance |
| 02/05/2009 | US20090035304 Use of Tgf-beta Antagonists to Limit Nephrotoxicity of Immunosuppressive Agents |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2019861A2 Kidney-derived stem cell population, identification and therapeutic use |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN101358173A Aspergillus niger ZJUT712 and application thereof in arctium fruit preparation by solid-state fermentation |
| 02/04/2009 | CN101357224A Kidney-tonifying and health-preserving preparation |
| 02/04/2009 | CN101357187A Medicine for treating the prostatitis |
| 02/04/2009 | CN101357186A Preparation method of medicine for treating the prostatitis |
| 02/04/2009 | CN101357152A Epiphyllum oxypetalum medicinal preparation |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/04/2009 | CN100457188C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457173C Medicine for treating disease due to kidney yang vacuity |
| 02/04/2009 | CN100457165C Chinese medicine for treating Hematuria and its preparing method and use |